Clinical Trial Update: Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated administering pegfilgrastim on the same day as chemotherapy in patients with Non-Hodgkin lymphoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED